As of 2025-12-17, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is (0.27) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.10 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -124.8%.
The range of the Relative Valuation is (0.22) - (0.33) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.3x - 2.0x | 1.6x |
| Forward P/E multiples | 1.3x - 2.0x | 1.6x |
| Fair Price | (0.22) - (0.33) | (0.27) |
| Upside | -119.9% - -129.8% | -124.8% |
| Date | P/E |
| 2025-12-15 | -6.40 |
| 2025-12-12 | -6.64 |
| 2025-12-11 | -7.12 |
| 2025-12-10 | -8.33 |
| 2025-12-09 | -9.72 |
| 2025-12-08 | -9.90 |
| 2025-12-05 | -9.54 |
| 2025-12-04 | -9.42 |
| 2025-12-03 | -9.66 |
| 2025-12-02 | -9.24 |
| 2025-12-01 | -9.66 |
| 2025-11-28 | -9.66 |
| 2025-11-27 | -9.30 |
| 2025-11-26 | -9.06 |
| 2025-11-25 | -9.24 |
| 2025-11-24 | -9.24 |
| 2025-11-21 | -8.39 |
| 2025-11-20 | -8.27 |
| 2025-11-19 | -8.69 |
| 2025-11-18 | -8.88 |
| 2025-11-17 | -8.81 |
| 2025-11-14 | -8.57 |
| 2025-11-13 | -8.27 |
| 2025-11-12 | -8.33 |
| 2025-11-11 | -8.63 |
| 2025-11-10 | -8.81 |
| 2025-11-07 | -8.75 |
| 2025-11-06 | -9.00 |
| 2025-11-05 | -9.24 |
| 2025-11-04 | -9.00 |
| 2025-11-03 | -8.94 |
| 2025-10-31 | -8.94 |
| 2025-10-30 | -8.94 |
| 2025-10-29 | -8.45 |
| 2025-10-28 | -9.78 |
| 2025-10-27 | -9.12 |
| 2025-10-24 | -9.54 |
| 2025-10-23 | -6.40 |
| 2025-10-22 | -5.62 |
| 2025-10-21 | -5.68 |
| 2025-10-20 | -5.80 |
| 2025-10-17 | -5.43 |
| 2025-10-16 | -5.37 |
| 2025-10-15 | -5.43 |
| 2025-10-14 | -5.55 |
| 2025-10-10 | -5.68 |
| 2025-10-09 | -5.68 |
| 2025-10-08 | -5.55 |
| 2025-10-07 | -5.62 |
| 2025-10-06 | -5.74 |